164 related articles for article (PubMed ID: 33338323)
1. Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomas.
Minatogawa H; Yasuda K; Dekura Y; Takao S; Matsuura T; Yoshimura T; Suzuki R; Yokota I; Fujima N; Onimaru R; Shimizu S; Aoyama H; Shirato H
J Appl Clin Med Phys; 2021 Jan; 22(1):174-183. PubMed ID: 33338323
[TBL] [Abstract][Full Text] [Related]
2. A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma.
Liu SW; Li JM; Chang JY; Yu JM; Chen Q; Jiang QA; Mu XK; Zhao MH; Tian Y; Wei QL
J Xray Sci Technol; 2010; 18(4):443-50. PubMed ID: 21045280
[TBL] [Abstract][Full Text] [Related]
3. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.
Müller BS; Duma MN; Kampfer S; Nill S; Oelfke U; Geinitz H; Wilkens JJ
Phys Med; 2015 May; 31(3):266-72. PubMed ID: 25724350
[TBL] [Abstract][Full Text] [Related]
4. Probability of normal tissue complications for hematologic and gastrointestinal toxicity in postoperative whole pelvic radiotherapy for gynecologic malignancies using intensity-modulated proton therapy with robust optimization.
Yoshimura T; Yamada R; Kinoshita R; Matsuura T; Kanehira T; Tamura H; Nishioka K; Yasuda K; Taguchi H; Katoh N; Kobashi K; Hashimoto T; Aoyama H
J Radiat Res; 2024 May; 65(3):369-378. PubMed ID: 38499489
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer.
Oonsiri S; Kitpanit S; Kannarunimit D; Chakkabat C; Lertbutsayanukul C; Prayongrat A
Phys Imaging Radiat Oncol; 2022 Apr; 22():51-56. PubMed ID: 35514527
[TBL] [Abstract][Full Text] [Related]
6. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
[TBL] [Abstract][Full Text] [Related]
7. Optimized treatment planning for prostate cancer comparing IMPT, VHEET and 15 MV IMXT.
Yeboah C; Sandison GA
Phys Med Biol; 2002 Jul; 47(13):2247-61. PubMed ID: 12164585
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study.
Flynn RT; Barbee DL; Mackie TR; Jeraj R
Phys Med Biol; 2007 Oct; 52(20):6073-91. PubMed ID: 17921573
[TBL] [Abstract][Full Text] [Related]
9. MR-based synthetic CT image for intensity-modulated proton treatment planning of nasopharyngeal carcinoma patients.
Chen S; Peng Y; Qin A; Liu Y; Zhao C; Deng X; Deraniyagala R; Stevens C; Ding X
Acta Oncol; 2022 Nov; 61(11):1417-1424. PubMed ID: 36305424
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity-modulated proton therapy.
Ren XY; He PK; Gao XS; Zhao ZL; Zhao B; Bai Y; Liu SW; Li K; Qin SB; Ma MW; Zhou J; Rong Y
J Appl Clin Med Phys; 2021 May; 22(5):79-88. PubMed ID: 33817981
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation.
Widesott L; Pierelli A; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Di Muzio N; Fazio F; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):589-96. PubMed ID: 18793962
[TBL] [Abstract][Full Text] [Related]
12. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.
Lewis GD; Holliday EB; Kocak-Uzel E; Hernandez M; Garden AS; Rosenthal DI; Frank SJ
Head Neck; 2016 Apr; 38 Suppl 1():E1886-95. PubMed ID: 26705956
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma.
Scandurra D; Meijer TWH; Free J; van den Hoek JGM; Kelder L; Oldehinkel E; Steenbakkers RJHM; Both S; Langendijk JA
Radiother Oncol; 2022 Mar; 168():221-228. PubMed ID: 35134448
[TBL] [Abstract][Full Text] [Related]
15. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
16. Improving workflow for adaptive proton therapy with predictive anatomical modelling: A proof of concept.
Zhang Y; Alshaikhi J; Amos RA; Lowe M; Tan W; Bär E; Royle G
Radiother Oncol; 2022 Aug; 173():93-101. PubMed ID: 35667573
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
18. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison.
Thorwarth D; Soukup M; Alber M
Radiother Oncol; 2008 Jan; 86(1):30-4. PubMed ID: 18061294
[TBL] [Abstract][Full Text] [Related]
19. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement.
Fellin F; Iacco M; D'Avino V; Tommasino F; Farace P; Palma G; Conson M; Giacomelli I; Zucchetti C; Falcinelli L; Amichetti M; Aristei C; Cella L
Acta Oncol; 2019 Jun; 58(6):934-942. PubMed ID: 30938217
[No Abstract] [Full Text] [Related]
20. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
